Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway integrates signals from amino acids—primarily leucine—as well as energy and growth factors to regulate cell growth, proliferation, and metabolism.[4][1] Leucine activates mTORC1 through direct mechanisms (via sensing by Sestrin2 and leucyl-tRNA synthetase)[4][2] and indirectly via its metabolism to acetyl-CoA, which further regulates mTORC1 activity in a cell-type-specific manner[3]. mTORC1 coordinates protein synthesis, cell growth, and metabolic adaptation, and its dysregulation is linked to cancer, metabolic disease, and age-related pathologies. While mTORC1 itself is a major drug target, the pathway described here encompasses both upstream metabolic events (leucine metabolism) and downstream signaling; thus, as a whole, it is not a single molecular target but rather a critical regulatory network.
Inhibition of mTOR kinase activity (suppresses protein synthesis and cell growth) and indirect modulation via amino acid mimetics or leucine analogues (modulates leucine sensing and thus mTORC1 activation).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanistic target of rapamycin complex 1 signaling pathway (mTORC1 signaling pathway).